Project Grant HT94252410561
Award Date
9/15/24
Completion Date
5/14/27
Dollars Obligated
$156K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Seattle, WA 98195, USA
Similar Awards
The Defense Health Agency awarded a $1,369,230 Project Grant to the New Jersey Institute of Technology (NJIT) under the Military Medical Research and Development program (CFDA 12.420). The grant, effective September 15, 2024, supports a 3-year research project titled "A Transcutaneous Electrode-Induced Valsalva-Like Maneuver for the Prevention of Blast Induced Pathophysiology and Behavioral Deficits in the Ferret." The research aims to develop a novel technique using transcutaneous...
The University of Washington was awarded a $1,810,550 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 1, 2023 through September 30, 2026 to investigate early chemodenervation of the detrusor muscle to preserve bladder compliance and function over the long term following spinal cord injury. The Military Medical Research and Development program supports basic,...
This federal Project Grant award, valued at $3,208,546.00, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant will fund the expansion of the Generalized Blast Exposure Value Tool to determine cumulative blast exposure thresholds in military populations. This research aims to transform healthcare for service members by developing innovative approaches to the prevention, diagnosis, and management of medical...
The Defense Health Agency awarded a $311,000 Project Grant to the University of Washington under the Military Medical Research and Development federal grant program (CFDA 12.420) to manage mitochondrial disorders through increased intestinal fermentation and reduced metabolic burden from January 1, 2023 to December 31, 2024. The University of Washington will deliver research to transform health care for service members and the public by investigating medical solutions for the battlefield through...
The University of Washington was awarded a $1,137,371 project grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from January 2021 through January 2025 to rapidly test a novel therapeutic strategy for COVID-19 using human organoids and blood vessel structures. The Military Medical Research and Development program aims to transform health care for service members and the public...
The U.S. Defense Health Agency awarded a $1,927,410.00 Project Grant to the University of Washington for the "CONTRAST-ENHANCED ULTRASOUND BIOMARKER FOR PROGNOSTICATION AND GUIDANCE OF SURGICAL TREATMENT IN ACUTE TRAUMATIC SPINAL CORD INJURY" project. The grant was awarded on August 31, 2023 and is scheduled for completion on August 30, 2026. This project falls under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced...
The Defense Health Agency awarded a $3.755 million Project Grant to the University of Wisconsin-Madison through the Military Medical Research and Development program (CFDA 12.420) to investigate dual orexin antagonist treatment to prevent neurobehavioral sequelae of traumatic brain injury from April 1, 2023 to March 31, 2027. The Military Medical Research and Development program supports innovative medical research to improve warfighter health and transform public healthcare. Under this award,...
The University of Washington received a $617,221 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant funds research to advance the efficacy, longevity, and safety of gene editing therapies for Duchenne muscular dystrophy (DMD). The 2-year grant period runs from August 15, 2023 to August 14, 2025. As a leading research institution, the University of Washington has previously received federal funding to support a...
The University of Washington received a $622,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the fibrolamellar carcinoma tumor microenvironment using human tumor slice cultures. The award has a performance period from July 1, 2024 to June 30, 2026. Through this funding, the University of Washington will investigate innovative approaches to improve understanding of the fibrolamellar carcinoma tumor...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,949,901.00 in funding to the Salisbury Foundation For Research And Education to conduct research on the relationship between blast exposure and cellular senescence in veterans. The award period runs from Sept. 1, 2025 to Aug. 31, 2029. The funded research aims to transform healthcare for military service members and the broader...